The National Human Genome Research Institute (NHGRI) has appointed Carolyn Hutter, Ph.D. the director of the Division of Genome Sciences - the NHGRI division that leads research aiming to understand the function of the human genome in health and disease, and seeks technologies that facilitate genomic discoveries. Dr. Hutter comes to the position with extensive experience leading large-scale genomics research programs.
The National Human Genome Research Institute's Division of Intramural Research will present the 14th Jeffrey M. Trent Lecture in Cancer Research on March 15, 2018, 12:00 - 1:00 p.m., at the Lipsett Amphitheater, Building 10 (Clinical Center), on the National Institutes of Health (NIH) Bethesda campus. Joan Brugge, Ph.D., co-director, Ludwig Center at Harvard Medical School, will deliver the lecture Role of the TRPA1 Ca2+-permeable Channel in Oxidative Stress Defenses in Cancer.
Researchers and clinicians are sequencing human genomes faster than ever, so considering the societal implications of genomic data and what we can learn from it is even more crucial. On January 29, 2018, NHGRI hosted a Reddit "Ask Me Anything" (AMA) with program directors from the Ethical, Legal and Societal Implications research program and NHGRI policy experts. Questions ran the gamut of who owns an individual's DNA and the information stored in it, to the implications of genetic testing for children and newborns.
The National Human Genome Research Institute today launched a new round of strategic planning that will establish a 2020 vision for genomics research aimed at accelerating scientific and medical breakthroughs. In developing the strategic plan, the institute will engage experts and diverse public communities to identify paradigm-shifting areas of genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
The Human Genome Project has been awarded the 2017 Prince Mahidol Award for ground-breaking advances in the field of medicine. The award will be received on behalf of the project by Eric Green, M.D., Ph.D., director of the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), and the institute responsible for leading NIH's effort in the project.